An Analysis of Urinary Proteases as Biomarkers for Hepatocellular Carcinoma-101423

Vanderbilt University Medical Center87 enrolled

Overview

Specific urine proteases or groups of these enzymes can be reliable biomarkers and an effective gauge of response to therapy in patients with hepatocellular carcinoma.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Hepatocellular Carcinoma Liver Disease

Eligibility

Sex: ALLMin age: 18 YearsMax age: 90 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Ability and willingness to provide written informed consent * Must be between 18-90 years of age at the time of consent * Ability to provide urine specimen at protocol-defined timepoints * Must have treatment interventions planned that are directly related to liver disease (excluding those assigned to group 3-Controls) Exclusion Criteria: * Suspected inability, e.g. unwillingness to comply with study procedures or unwillingness to provide written consent

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.